Diabetic Gastroparesis Are you Diabetic and have symptoms of nausea or vomiting, abdominal pain, bloating, or early fullness after meals?

Last updated: N/A
Sponsor: N/A
Overall Status: Active - Recruiting

Phase

3

Condition

Stomach Discomfort

Diabetes Mellitus, Type 1

Diabetes Mellitus, Type 2

Treatment

N/A

Clinical Study ID

TX206880
  • Ages 18-75
  • All Genders

Study Summary

We are enrolling volunteers for a clinical research study evaluating the safety and efficacy of an investigational drug for individuals with Diabetic Gastroparesis.

Qualified participants must:

  • Ages 18 to 75
  • Have Diabetes Type 1 or 2 at least 5 years
  • Have symptoms of nausea or vomiting, abdominal pain, bloating or early signs of fullness after meals
  • Or been diagnosed with Diabetic Gastroparesis for at least 3 months

Eligibility Criteria

Inclusion

  • 2 episodes of vomiting w/in 2 weeks before screening
  • HbA1c < 11%
  • BMI < 35

Study Design

Study Start date:
Estimated Completion Date:

Study Description

*Study drug is Relamorelin vs placebo (injection 2 times a day) *7 visits for approximately 3 months *Qualified participants may receive compensation for time and travel